Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism CCR8 inhibitor(C-C chemokine receptor type 8 inhibitor) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Genuv, Inc.Startup |
Active Organization Genuv, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Discovery | KR | Genuv, Inc.Startup | 11 Mar 2022 |